BETHLEHEM, Pa., Feb. 22, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that its OraQuick ® HCV Rapid Antibody Test has now been approved by the U.S. Food and Drug ...
BETHLEHEM, Pa., March 23, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that it has submitted to the U.S. Food and Drug Administration ("FDA") an application for a ...
Says filing for oral version of HCV test delayed Says FDA commented on lower sensitivity of tests Q2 loss/shr $0.01 vs. est loss/shr $0.07 Q2 rev $19.2 mln vs. est $17.5 mln Aug 4 (Reuters) - OraSure ...
Bethlehem, PA-based OraSure Technologies (NASDAQ:OSUR) has received the FDA's OK for its OraQuick hepatitis C rapid antibody test. It is the the first rapid HCV test approved by the FDA for use in the ...
OraSure Technologies (NASDAQ: OSUR)stock is up 24% at 12:53 p.m. EST after the company announced solid fourth-quarter earnings yesterday after the closing bell. The test maker also announced guidance ...
SILVER SPRING, Md. The Food and Drug Administration has approved a new rapid blood test for detecting hepatitis C, the agency said Friday. The FDA approved Bethlehem, Pa.-based OraSure Technologies’ ...
In two separate moves, the FDA has approved the first assay to detect both antigen and antibodies to HIV and the first rapid blood test for hepatitis C virus (HCV) antibodies. The Architect HIV Ag/Ab ...
A partnership between OraSure Technologies (Bethlehem, Pennsylvania) and AbbVie (North Chicago) could put testing individuals at-risk for hepatitis C (HCV) in the forefront of testing for the disease.
Please provide your email address to receive an email when new articles are posted on . Findings presented at the International Liver Congress suggest that point-of-care testing for hepatitis C virus ...
OraSure Technologies has submitted an application to the U.S. Food and Drug Administration for approval of a rapid hepatitis C test, according to a news release. The Bethlehem-based company is seeking ...
Truckers are five times more likely than the general population to carry hepatitis C virus (HCV), a dangerous blood-born infection that can live in the body for up to 40 years with no symptoms. To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results